tenofovir has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, D; Cinausero, M; Fusi, M; Gervasoni, C; Londero, A; Tascini, C | 1 |
| Burdick, R; Chaipan, C; Delviks-Frankenberry, KA; Hu, WS; Paprotka, T; Pathak, VK; Venkatachari, NJ | 1 |
2 other study(ies) available for tenofovir and Cancer of Prostate
| Article | Year |
|---|---|
Effects of the androgen receptor inhibitor enzalutamide on the pharmacokinetics of dolutegravir and tenofovir: a case report.
Topics: Androgen Receptor Antagonists; Benzamides; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Nitriles; Oxazines; Phenylthiohydantoin; Piperazines; Prostatic Neoplasms; Pyridones; Receptors, Androgen; Tenofovir | 2022 |
Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cytidine Deaminase; Gammaretrovirus; Humans; Leukemia Virus, Murine; Male; Mice; Mutation; Organophosphonates; Prostatic Neoplasms; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections; Zidovudine | 2010 |